Efficacy of Combination Blinatumomab and Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) and Chronic Myeloid Leukemia in Lymphoid Blast Phase (CMLBP) in a Real World Setting

被引：0

作者：

Tobon, Katherine ^{[1
]}

Consalvo, Kylie ^{[2
]}

Kareem, Syeda Saba ^{[1
]}

Lancet, Jeffrey E. ^{[1
]}

Komrokji, Rami S. ^{[1
]}

Pinilla-Ibarz, Javier ^{[3
]}

Sallman, David ^{[1
]}

Eatrides, Jennifer ^{[4
]}

Walker, Alison R. ^{[1
]}

Chavez, Julio C. ^{[1
]}

Isenalumhe, Leidy Lismeris ^{[1
]}

Shah, Bijal ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Community & Satellite Oncol, Tampa, FL USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-201486

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2821 / 2821

页数：1

共 50 条

[41] Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study
Short, Nicholas
Kantarjian, Hagop
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval
Chien, Kelly S.
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas C.
Macaron, Walid
Haddad, Fadi
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2022, 140
[42] Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse
Short, Nicholas J.
Kantarjian, Hagop
Jain, Nitin
Takahashi, Koichi
Furudate, Ken
Senapati, Jayastu
Haddad, Fadi G.
Karrar, Omer
Kadia, Tapan M.
Chien, Kelly S.
Sasaki, Koji
Kugler, Eitan
Garris, Rebecca
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2024, 144 : 837 - 838
[43] Dasatinib (Sprycel®) in patients with philadelphia chromosome-positive acute lymphoblastic leukemia or lymphoid blast phase chronic myeloid leukemia after imatinib failure:: A single-center experience
Piccaluga, P. P.
Rosti, G.
Rondoni, M.
Amabile, M.
Bosi, C.
Castagnetti, F.
Iacobucci, L.
Laterza, C.
Palandri, F.
Paolini, S.
Soverini, S.
Verlicchi, L.
Visani, G.
Baccarani, M.
Martinelli, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 181 - 182
[44] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
Samra, Bachar
Kantarjian, Hagop M.
Sasaki, Koji
Konopleva, Marina Y.
Khouri, Rita
O'Brien, Susan M.
Ferrajoli, Alessandra
Nunez, Cesar
Kadia, Tapan M.
Jabbour, Elias
BLOOD, 2019, 134
[45] Outcome of Patients With Chronic Myeloid Leukemia in Lymphoid Blastic Phase and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Hyper-CVAD and Dasatinib
Morita, Kiyomi
Kantarjian, Hagop M.
Sasaki, Koji
Issa, Ghayas C.
Jain, Nitin
Konopleva, Marina
Short, Nicholas J.
Takahashi, Koichi
DiNardo, Courtney D.
Kadia, Tapan M.
Garcia-Manero, Guillermo
Daver, Naval
Montalban Bravo, Guillermo
Cortes, Jorge E.
Ravandi, Farhad
Jabbour, Elias
CANCER, 2021, 127 (15) : 2641 - 2647
[46] Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial
Haddad, Fadi G.
Jabbour, Elias
Short, Nicholas J.
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval
Nasnas, Cedric
Mayor, Ejiroghene
Nasnas, Patrice Eric
Deen, Wuliamatu
Zoghbi, Marianne
Thankachan, Jennifer
Loiselle, Christopher
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop M.
BLOOD, 2023, 142
[47] Phase II study of combination of the HyperCVAD regimen with dasatinib in patients with Philadelphia chromosome (Ph) or BCR-ABL positive acute lymphoblastic leukemia (ALL) and lymphoid blast phase chronic myeloid leukemia (CML-LB)
Ravandi, Farhad
Thomas, Deborah
Kantarjian, Hagop
Faderl, Stefan
Koller, Charles
Brown, Devri
Garris, Rebecca
Borthakur, Gautam
Burger, Jan
Kebriaei, Partow
Jorgensen, Jeffrey
Jones, Dan
Cortes, Jorge
O'Brien, Susan
BLOOD, 2007, 110 (11) : 828A - 828A
[48] Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph plus ) acute myeloid leukemia (AML) and chronic myeloid leukemia myeloid blast phase (CML MBP).
Maiti, Abhishek
Ravandi, Farhad
Cortes, Jorge E.
Jabbour, Elias
Marx, Kayleigh
Daver, Naval Guastad
Garcia-Manero, Guillermo
Konopleva, Marina
Benton, Christopher Brent
Masarova, Lucia
Dinardo, Courtney Denton
Bose, Prithviraj
Naqvi, Kiran
Pierce, Sherry A.
Kantarjian, Hagop M.
Short, Nicholas James
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[49] Combination of the hyperCVAD Regimen with Dasatinib is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Meyloid Leukemia (CML-LB)
Jabbour, Elias
O'Brien, Susan
Thomas, Deborah A.
Faderl, Stefan
Koller, Charles Asa
Dara, Samuel
Garris, Rebecca
Cortes, Jorge
Kantadian, Hagop M.
Ravandi, Farhad
BLOOD, 2008, 112 (11) : 1004 - 1004
[50] SAFETY AND TOLERABILITY OF DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL): POOLED ANALYSIS OF OVER 2400 PATIENTS
Saglio, G.
le Coutre, P.
Cortes, J.
Mayer, J.
Rowlings, P.
Subar, M.
Preston, J.
Shah, N.
HAEMATOLOGICA, 2014, 99 : 329 - 329

← 1 2 3 4 5 →